이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
More Korean firms join U.S. Cancer Moonshot project
- Collected
- 2023.10.30
- Distributed
- 2023.10.31
- Source
- Go Direct
According to industry sources on Sunday, companies including GC Cell Corp., HLB Co., Lunit Inc., Prestige Biopharma Ltd., LabGenomics Co., NgeneBio Co. Ltd., BL Science Corp., Gencurix Inc., Cubebio, EONE Diagnomics Genome Center Co., and Cytogen Inc. have joined the ambitious program to date.
The Cancer Moonshot project, initiated during the presidency of Barack Obama, is a commitment to provide comprehensive national support for cancer prevention, early detection, and therapeutic medicine development. The project’s goals were further amplified by the incumbent Biden administration, which aims to reduce cancer-related mortality by over 50 percent in the next 25 years. The U.S. government plans to allocate an annual budget of $1.8 billion towards the project, focusing on digital innovations across all areas of oncology.
Renowned cancer centers, such as MD Anderson, and global information technology (IT) giants, such as Intel and Amazon, are also participating in the project.
By Shim Hee-jin and Minu Kim
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]